Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar®) in older patients with essential hypertension: Subgroup analysis from the Sevikar study
Article in Experimental and Therapeutic Medicine (December 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study
Article in Journal of Clinical Hypertension (September 2023)
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors
Article in Advances in Therapy (August 2023)